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Abstract
Ex vivo lung perfusion (EVLP) is a promising procedure for evaluation, reconditioning, and
treatment of marginal lungs before transplantation. Small animal models can contribute to
improve clinical development of this technique and represent a substantial platform for bio-
molecular investigations. However, to accomplish this purpose, EVLP models must sustain
a prolonged reperfusion without pharmacological interventions. Currently available proto-
cols only partly satisfy this need. The aim of the present research was accomplishment and
optimization of a reproducible model for a protracted rat EVLP in the absence of anti-inflam-
matory treatment. A 180 min, uninjured and untreated perfusion was achieved through a
stepwise implementation of the protocol. Flow rate, temperature, and tidal volume were
gradually increased during the initial reperfusion phase to reduce hemodynamic and oxida-
tive stress. Low flow rate combined with open atrium and protective ventilation strategy
were applied to prevent lung damage. The videos enclosed show management of the most
critical technical steps. The stability and reproducibility of the present procedure were con-
firmed by lung function evaluation and edema assessment. The meticulous description of
the protocol provided in this paper can enable other laboratories to reproduce it effortlessly,
supporting research in the EVLP field.
Introduction
Lung transplantation is the only therapeutic option for patients with end-stage organ failure.
However, graft shortage is a major limiting factor to clinical success. Indeed, it is estimated
that only 15–20% of potential lungs from multiorgan donors are currently suitable for trans-
plantation [1].
Ex vivo lung perfusion (EVLP) is a promising strategy to cope with this problem. This tech-
nique was initially developed by Steen and co-workers to evaluate lungs from donation after
cardiac death [2]. Subsequently, EVLP was implemented as a method to preserve and repair
marginal organs prior to transplant [3–5].
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Many animal models of EVLP have been developed to support clinical use. Because of their
appropriate human-like lung size, large animals, such as pigs, have been broadly used to
exploit this system [6, 7]. While these models were crucial to improve specific technical skills,
small animal models can offer better means to identify the pathophysiological bio-molecular
changes associated with ex vivo perfusion [8]. This kind of information is needed as the mech-
anism(s) underlying beneficial effects of extracorporeal reconditioning on donor lungs are
largely unknown. Further, it is equally important to identify potential damage of EVLP. Analy-
sis of molecular changes that occur in the lung at definite procedure steps can help correction
through targeted interventions.
The present investigation is part of a broader research project aimed at identification and
characterization of molecular changes induced in the lung by ex vivo perfusion and, eventu-
ally, evaluation of different therapeutic interventions. Set up and optimization of a simple and
reproducible model for a normothermic and protracted rat EVLP was the main focus in this
study. Indeed, a rat EVLP protocol that is stable over time is a solid foundation to any further
research in the field. Particular efforts were devoted to safely prolong perfusion time without
using pharmacological treatments. To accomplish this purpose, several technical issues associ-
ated with lung damage were identified and implemented. With the reliable support of videos,
this study provides a detailed identification of the critical steps connected with the procedure
and their successful management. The meticulous description of our protocol will enable
other laboratories to reproduce it effortlessly, reducing the number of experiments in full
respect of the 3Rs principles [9].
Materials and Methods
Animals
The experiments were performed in strict accordance with the recommendations in the Guide
for the Care and Use of Laboratory Animals of the National Institutes of Health, at the Center
for Preclinical Investigation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,
Milan, Italy. The experimental protocol was approved by the Italian Institute of Health (Permit
Number: 5/13).
Adult Sprague–Dawley male rats (Charles River, Calco, Lecco, Italy) weighing 270–330 g
were housed in a ventilated cage system (Tecniplast S.p.A., Varese, Italy) at 22 ± 1˚C, 55 ± 5%
humidity, on a 12 h dark/light cycle, and were allowed free access to rat chow feed and water
ad libitum.
Reagents and instruments
The reagents and instruments used in this protocol are shown in Tables 1 and 2.
Anesthesia and pre-operative preparation
All procedures were performed under sterile conditions.
Rats were anesthetized with an intraperitoneal injection of 80 mg/kg thiopental sodium.
The animals, placed on a surgical heating pad in supine position, received an intravenous
injection of 600 IU heparin. Rectal temperature was continuously monitored.
Isolated lung perfusion system
The perfusion circuit consisted of a glass chamber, a roller pump, a reservoir, a bubble trap,
and silicon tubing. The glass chamber and reservoir were equipped with a water-jacket to con-
trol the perfusate temperature through a heat exchanger. A small animal ventilator was used.
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Gas analysis of perfusate samples
Inflow and outflow perfusate composition, from reservoir and left auricle respectively, was
hourly monitored with an automatic gas analyzer.
Table 2. Instruments employed.
Instrument Manufacturer
Temperature control unit HB 101/2 RS Panlab Harvard Apparatus, Barcelona, Spain
Surgical heating pad Panlab Harvard Apparatus
Isolated lung perfusion systems size 2 Hugo Sachs Elektronik, Harvard Apparatus GmbH, March-
Hugstetten, Germany
Roller pump Ismatec, Wertheim, Germany
Heat exchanger Ecoline E 103 Lauda Dr. R. Wobser Gmbh & Co. Kg, Lauda-Konigshofen,
Germany
Harvard model 683 small animal
ventilator
Harvard Apparatus, Holliston, Massachusetts, United States
Automatic blood gas analyzer ABL 800
FLEX
A. De Mori Strumenti, Milano, Italy
Data acquisition software Colligo Elekton, Milano, Italy
Analytical balance ABT 100-5M KERN & SOHN GmbH, Balingen, Germany
Oven LTE Scientific, Greenfield, United Kingdom
14 G tube Delta Med S.p.A, Viadana, Italy
2.0/2.5 mm pulmonary cannula Hugo Sachs Elektronik
Double-headed surgical microscope
OPMI 1-F
Zeiss West Germany, Oberkochen, Germany
1.3 mm temperature probe Panlab Harvard Apparatus
5F Swan-Ganz catheter Pulsion Medical System SE, Feldkirchen, Germany
Laminar flow hood Gelaire ICN Biomedicals, Sydney, Australia
Filtropur V 100 0.22 μm Sarstedt, Numbrecht, Germany
doi:10.1371/journal.pone.0167898.t002
Table 1. Reagents employed.
Reagent Manufacturer
Thiopental sodium, 0.5 g Inresa Arzneimittel GmbH, Freiburg, Germany
Heparin, 5000 UI/ml Pharmatex Italia S.r.l., Milano, Italy
Perfadex® XVIVO Perfusion AB, Gotebo¨rg, Sweden
NaHCO3, 8.4% S.A.L.F. S.p.A. Laboratorio Farmacologico, Bergamo,
Italy
CaCl2, 1.36 mEq/ml Bioindustria L.I.M. S.p.A., Novi Ligure, Italy
Mucasol™ universal detergent Sigma-Aldrich, St. Louis, Missouri, United States
Basic Glutaster Farmec, Settimo di Pescantina, Italy
Albumin, 0.2 g/ml 20% immuno Baxter S.p.A., Roma, Italy
NaCl, 0.9% Baxter S.p.A.
Amphotericin B, 250 μg/ml Life Technologies, Foster City, California, United States
Glucose, 33% B. Braun, Melsungen, Germany
KCl, 2 mEq/ml B. Braun
K3PO4, 2 mEq/ml S.A.L.F. S.p.A. Laboratorio Farmacologico
MgSO4, 0.8 mEq/ml S.A.L.F. S.p.A. Laboratorio Farmacologico
Cefazolin, 0.1 g/ml Pfizer Italia S.r.l., Latina, Italy
Gas mixture of CO2 (5%), O2 (21%) and N2
(74%)
Sapio S.r.l., Monza, Italy
LB agar Sigma-Aldrich
doi:10.1371/journal.pone.0167898.t001
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Mean pulmonary artery and airway pressure measurements
During the whole experiment, mean pulmonary artery pressure (PAP), positive end expiratory
pressure (PEEP), and peak inspiratory pressure (Ppeak) were continuously recorded via an
amplifier connected to the pulmonary and tracheal cannulae.
Total pulmonary vascular resistance (TPVR) was calculated using the formula:
80ðPAP  WPÞ
PAF ,
where PAF is the pulmonary artery flow and WP the wedge pressure (set to 0).
Wet-to-dry weight ratio
At the end of the ex vivo perfusion, the right superior lobe was weighed with an analytical bal-
ance and dried in an oven at 50˚C for 24 h. Wet-to-dry ratio (W/D) was calculated and used as
an index of pulmonary edema. Lungs harvested from rats in basal conditions (n = 10) were
used as controls.
Statistical analysis
All results are presented as mean ± standard error of the mean (SEM) or as the median [first
quartile–third quartile]. Statistical analysis was performed using t-test or one-way analysis of
variance (ANOVA) for repeated measures, followed by Tukey’s multiple comparison test to
evaluate differences at each time points. Non-linear regression analysis was used to investigate
correlation, whereas agreement between measurements performed on samples collected from
left auricle and reservoir was explored using linear regression and Bland-Altman analysis. Lim-
its of agreement were computed as the average of the differences (bias) plus and minus 2 times
the standard deviation. A probability value <0.05 was considered significant. Data were ana-
lyzed using Sigma Stat 11.0 dedicated software (Systat Software Inc., San Jose, United States).
Results
Over a 5 month-period, 44 rats were subjected to heart-lung block harvest. Two animals were
excluded, one because of air embolism during cannulation of the pulmonary artery and the
other because of lung damage during harvest. The ex vivo procedure was performed on 42
lungs; 5 of them were discarded, 4 because of air embolism during EVLP and one due to a pro-
cedural mistake. Thirty-seven lungs were successfully perfused for 180 min and were included
in a randomized single-blind study; 27 of these organs were subjected to different therapeutic
interventions as part of a larger research program. Surgical outcomes and functional parame-
ters from the 10 untreated experiments are the subject of the present research and are
described in detail in this article.
Surgical procedure
In situ lung function evaluation. The whole procedure was conducted with the aid of a
surgical microscope. The trachea was cannulated with a 14 G tube and monitoring of airway
pressure was started. The abdomen was entered with a midline xiphopubic incision and infe-
rior vena cava was sectioned. The surgical heating pad was then removed and rats were left at
room temperature (RT). Subsequently, continuous positive airway pressure (CPAP) with
PEEP of 3 cmH2O and 100% oxygen 0.3 L/min was started. The thorax was entered through a
midline incision and a recruitment maneuver (RM) aimed at expansion of pulmonary atelecta-
sis was performed using 25 ml/kg air at RT. One ml-aliquots of ambient air were insufflated
into the lungs to measure total lung capacity (TLC), defined as the volume at which the pres-
sure-volume curve shows an upper inflection point (overstretch) [10]. A volume correspond-
ing to half TLC was used to calculate the basal elastance (S1 Video).
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In situ lung perfusion. Diaphragm, pulmonary ligaments and pericardium were sec-
tioned and thymus removed. Ascending aorta and pulmonary artery were encircled. Pulmo-
nary artery cannulation was performed with a 2.0/2.5 mm cannula through a right ventricular
incision, after careful removal of air bubbles. Atrial auricles and heart apex were resected to
vent pulmonary circulation (S2 Video).
CPAP was replaced by volume controlled ventilation (VCV) using ambient air, with tidal
volume (VT) of 6 ml/kg, PEEP of 2 cmH2O and respiratory rate (RR) of 10 bpm. Lungs were
then flushed at 25 cm H2O pressure with 60 ml/kg of ice-cold Perfadex1 buffered with 10
mEq/L of 8.4% NaHCO3 and 0.8 mEq/L of CaCl2. At the end of flushing, ventilation was
stopped and lungs were kept inflated during retrieval (S3 Video).
Heart-lung block harvest. Diaphragm and suprahepatic vena cava were dissected and
lung ligaments sectioned. The lungs were gently turned upside down with two cotton swabs to
perform posterior dissection. Trachea was isolated from esophagus and cervical vasculature.
Harvest of the heart-lung block was performed maintaining both tracheal and pulmonary can-
nulae in place. After harvest, the lungs were still inflated and appeared homogeneously per-
fused (S4 Video). At this stage, we recommend particular caution in handling lungs, avoiding
torsion of the hilar structure.
Surgical outcomes. Time periods required for surgical preparation (from heparin
injection to flushing), heart-lung block procurement (from flushing to harvest), and lung con-
nection (from harvest to connection to the circuit) were examined as indexes of technical
improvement. Nonlinear regression analysis of 37 experiments over a 5 month-period showed
a significant decrease in procurement time (R = 0.660, p = 0.0003, Fig 1A), whereas duration
of surgical preparation and connection steps remained unchanged (R = 0.291, p = 0.397, Fig
1B and R = 0.299, p = 0.370, Fig 1C, respectively). The 10 rats (300 ± 3 g) included in the pres-
ent paper were subjected to 36.6 ± 1.9 min total operation time (from heparin injection to lung
harvest). Specifically, time for surgical preparation was 26.9 ± 1.4 min, flushing 1.3 ± 0.1 min,
procurement 9.8 ± 0.8 min, cold ischemia (from flushing to ex vivo perfusion) 15.9 ± 1.0 min,
and connection 7.3 ± 1.1 min. Start core temperature, recorded during systemic hepariniza-
tion, was 35.6 ± 0.3˚C and basal compliance was 0.38 ± 0.01 ml/cmH2O.
Fig 1. Learning curves. (A) Surgical preparation time (from heparin administration to flushing; R = 0.291, p = 0.397). (B) Procurement time (from
flushing to harvest; R = 0.660, p = 0.0003); (C) Connection time (from harvest to lung connection to the circuit; R = 0.299, p = 0.370). Nonlinear
regression analysis.
doi:10.1371/journal.pone.0167898.g001
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EVLP procedure
Perfusion solution. The present protocol used an acellular perfusion fluid with extra-cel-
lular electrolyte composition. The solution was freshly prepared in sterile conditions in a lami-
nar flow hood, using: albumin, NaCl, Perfadex1, amphotericin B, glucose, CaCl2, KCl, K3PO4,
MgSO4, and heparin. Although two separate lots of albumin with different sodium concentra-
tions were used, electrolyte composition was maintained stable. Characteristics of the two
solutions were: osmolality 294 and 286 mOsm/kg; albumin 8.8 and 8.9 g/dl; total protein 9.4 g/
dl for both lots. The perfusion fluid was filtered using a vacuum filtration unit to remove any
particulate impurity or bacterial contamination and stored for a maximum of 5 days to avoid
bacterial growth.
Before each experiment, the fluid was added with cefazolin and NaHCO3, whereas no treat-
ment with corticosteroids or other anti-inflammatory drugs was performed.
Isolated lung perfusion system. The heart-lung block was placed onto the glass chamber
modified to let the lung dorsal side lay on a modeled ad hoc, perforated surface. The lungs
were connected to the circuit through the pulmonary cannula and to the ventilator through
the tracheal cannula. The chamber was closed with a polystyrene lid to maintain humidity.
Temperature inside the chamber was recorded with a 1.3 mm probe. In preliminary experi-
ments, perfusate temperature was measured using a 5F Swan-Ganz catheter probe, positioned
in the pulmonary cannula. The observation was that, in order to obtain a lung temperature of
37.5˚C, the heat-exchanger had to be set at 42˚C. Indeed, we found that the temperature
recorded in the pulmonary cannula was considerably lower relative to that set in the instru-
ment (data not shown). This information is very important for an appropriate heat-exchanger
setting.
The circuit was primed with 110–140 ml of perfusion fluid according to rat weight. In our
experience, correct priming of the perfusion system is essential to avoid air embolism. The
EVLP system is showed in S5 Video. At the end of each experiment, the perfusion apparatus
was washed with H2O2, Mucasol
TM universal detergent and Basic Glutaster.
Isolated lung perfusion protocol. Lung perfusion was started when pH of the solution
reached 7.2. As shown in Fig 2, ex vivo perfusion was maintained for 180 min and included 2
Fig 2. Protocol timeline. Schematic overview of EVLP protocol. Abbreviations: VT, tidal volume; RR, respiratory rate; PEEP, positive end
expiratory pressure.
doi:10.1371/journal.pone.0167898.g002
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phases. The first 40-min phase, named “reperfusion” (also denoted “stabilization” or “ramp-
up”), included a gradual rise of PAF, temperature, and VT. Initial PAF was set at 20% of 6 ml/
min/g of predicted lung weight (PLW), calculated using the formula: PLW (g) = 0.0053 × body
weight (g) − 0.48 [11]. PAF was progressively increased to 100%, equivalent to 5.71 and 7.61
ml/min for rats weighing 270 and 330 g, respectively. Temperature was gradually increased
from 25˚ to 42˚C in 25 min. When the lung reached a normothermic state, VCV ventilation
was started using a gas mixture of CO2 (5%), O2 (21%) and N2 (74%). RR was set at 35 bpm,
PEEP at 3 cmH2O, and initial VT at 5 ml/kg. Over the next 10 min, VT was increased to 7 ml/
kg (S6 Video). During the first 15 min of the reperfusion phase, the perfusate draining from
the left atrium was collected and discarded every 5 min. Thereafter, the outflow perfusate was
let to re-circulate into the reservoir.
The second phase, named “reconditioning” (also denoted “steady-state”), began when all
parameters reached their target value. Two RMs were applied at 40 and 175 min by manually
inflating the lungs at 20 cmH2O with ambient air (S6 Video). During this procedure, PAF was
reduced to half the set flow rate.
At the end of ex vivo perfusion, biopsies were performed for edema evaluation and 1 ml
perfusate was dispensed to LB agar plates. Absence of bacterial growth after 4 days at 37˚C
indicated no contamination.
EVLP effects
Gas analysis of perfusate samples. Characteristics of the perfusion solution at priming
(time 0) and in samples collected from the auricle at 60, 120, and 180 min are shown in
Table 3. All measured parameters changed over time (p<0.001). Of note, glucose concentra-
tion decreased from 192 ± 3 mg/dl at priming to 175 ± 2 mg/dl at 180 min, whereas lactate
increased from 0.3 ± 0.0 mmol/L at 60 min to 0.9 ± 0.1 mmol/L at 180. Linear regression analy-
sis showed a significant correlation for all the measured parameters in samples withdrawn
from the auricle and those from the reservoir (R0.801; p<0.001), with the only exception of
Table 3. Changes over time in perfusion fluid parameters.
Perfusion time, min
0 60 120 180
pH 7.224 ± 0.006 7.340 ± 0.007a 7.336 ± 0.006a 7.331 ± 0.008a
BE, mmol/L -11.8 ± 0.4 -11.4 ± 0.4 -12.1 ± 0.3b -12.7 ± 0.4a,b
pO2, mmHg 175 ± 2 155 ± 3 154 ± 3a 153 ± 3a
pCO2, mmHg 36.2 ± 0.8 25.3 ± 0.5 24.2 ± 0.5a 23.6 ± 0.5a,b
K+, mmol/L 4.6 [4.5–4.8] 4.7 [4.7–4.9]a 4.7 [4.7–4.9]a 4.8 [4.7–4.9]a
Na+, mmol/L 145 ± 0 146 ± 0a 147 ± 0a,b 148 ± 0a,b,c
Ca2+, mmol/L 0.67 ± 0.01 0.61 ± 0.01a 0.61 ± 0.01a 0.61 ± 0.01a
Cl-, mmol/L 107 ± 2 110 ± 1a 112 ± 1a,b 113 ± 1a,b
Glc, mg/dl 192 ± 3 186 ± 2 181 ± 2a 175 ± 2a,b
Lac, mmol/L 0.0 ± 0.0 0.3 ± 0.0a 0.6 ± 0.1a,b 0.9 ± 0.1a,b,c
Perfusate composition was monitored hourly using an automatic gas analyzer. Results are expressed as mean ± SEM or as the median [first quartile–third
quartile]. One-way repeated measures ANOVA; p value was <0.001 for each parameter considered. Tukey’s multiple comparison test
a p<0.05 vs time 0
b p<0.05 vs time 60
c p<0.05 vs time 120. Abbreviations: BE, base excess; pO2, partial pressure of oxygen; pCO2, partial pressure of carbon dioxide; Glc, glycemia; Lac, lactate
concentration.
doi:10.1371/journal.pone.0167898.t003
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pO2 (R = 0.0937, p = 0.622) (S1 Fig, panel A). Bland-Altman plots showed that electrolyte and
metabolite concentration fell within the limits of agreement (S1 Fig, panel B), whereas a con-
stant error in pO2 and pH measurements was revealed.
Mean pulmonary artery and airway pressures. PAP increased over the 180 min observa-
tion time (p<0.001) (Fig 3A) with no significant difference among the reconditioning phase
time points (from 45 to 180 min). TPVR significantly decreased during the EVLP procedure
(p<0.001) (Fig 3B). After RMs at 40 and 175 min, there was a reduction of Ppeak (Fig 3C,
p<0.001), whereas dynamic compliance raised (Fig 3D, p<0.001), with a significant difference
at 180 min vs 30, 90, 120, 150, and 45 min vs 30, 120 and 150 (p<0.05).
Wet-to-dry weight ratio. The lungs were homogeneously white, compact, with no visible
signs of edema or trauma.
Fig 3. Lung parameter changes during EVLP. (A) Pulmonary artery pressure (PAP). (B) Total pulmonary vascular resistance (TPVR). (C)
Peak inspiratory pressure (Ppeak). (D) Dynamic compliance (Cdyn). Pressure recruitment maneuvers (RMs) were performed at 40 and 175 min.
Results are expressed as the mean ± SEM (N = 10). One-way repeated measures ANOVA; p value was <0.001 for each parameter considered.
Tukey’s multiple comparison test.
doi:10.1371/journal.pone.0167898.g003
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Wet-to-dry ratio was similar in EVLP and control group: 5.1 ± 0.2 and 5.0 ± 0.1, respec-
tively (p = 0.903).
Discussion
The present study describes a successful protocol to perform normothermic ex vivo perfusion
using rat lungs. A remarkable outcome was a substantial extension of uninjured ex vivo perfu-
sion to 180 min in the absence of pharmacological interventions. This successful achievement
stems from our expertise in both clinical [12–14] and pre-clinical [15, 16] use of the isolated
lung. The meticulous procedure description includes videos that show how critical steps were
managed and solved.
Clinical EVLP is a major pathway to successful transplantation of marginal lungs. However,
this promising technique still requires preclinical investigations able to explore procedural
adjustments and/or pharmacological interventions. The model made available in the present
research could be a dependable basis for such achievement.
Small animal models of EVLP have a remarkable potential as a factual support to clinical
application of this advanced technique. However, translational potential of an effective experi-
mental EVLP requires prolonged perfusion length to reproduce the clinical condition. Indeed,
short duration is a weakness of currently used rat models in which uninjured perfusion does
not generally exceed 30–120 min (Table 4) [17–25]. This is likely due to rodent lung greater
brittleness relative to human or porcine organs and to their tendency to develop atelectasis or
edema in a shorter time [8].
Attempts to prolong ex vivo perfusion included the use of anti-inflammatory treatments
(Table 4). Noda and colleagues [26] showed that addition of methylprednisolone allowed to
prolong perfusion up to 4 h, whereas the untreated lung developed edema within 1 h. Simi-
larly, with the use of the anti-inflammatory molecule meclofenamate, the Hodyc’s group [27]
was able to prevent edema over 3 h EVLP.
Other studies showed prolonged EVLP without anti-inflammatory therapy but some issues
in these experiments deserve consideration (see Tables 5 and 6 for settings of recently reported
Table 4. General protocol features and perfusion fluid characteristics of recently reported EVLP rat models.
General setting Perfusion solution
Author, ref Time, min Atrium De-oxygenator Type RBC Antibiotics Heparin Anti-inflammatory
Present model 180 open no in-house no yes yes no
Nelson[22] 60 closed yes NR NR NR NR NR
Noda[26] 240 closed yes STEEN NR yes NR yes
Markou[29] 140 closed yes in-house yes NR yes NR
Motoyama[21] 60 closed yes STEEN NR NR yes NR
Dacho[28] 180 open NR Krebs-Henseleit NR NR NR NR
Pêgo-Fernandes[30] 60 closed yes saline yes NR yes NR
Hodyc[27] 180 closed no in-house NR NR NR yes
Inokawa[19] 75 closed no In-house yes/no NR NR NR
Hirata [17] A 120 open yesB venous blood yes NR yes NR
Liu[23] A 120 open yesB venous blood yes NR yes NR
The analysis included rat EVLP protocols recently published.
A Single lung ex vivo perfusion.
B Lung isolated from another rat.
Abbreviations: RBC, red blood cells; NR, not reported.
doi:10.1371/journal.pone.0167898.t004
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EVLP rat models). In Dacho’s protocol [28] there was a successful 3 h untreated perfusion, but
the procedure involved a very low flow rate that would likely be insufficient to sustain lung
metabolism (Table 6). Conversely, Markou and co-workers [29] performed a 140 min EVLP,
but unfortunately presence of lung edema was not assessed as this outcome was outside their
study aim.
In the present research, the 180 min-perfusion goal was reached via a stringent procedure
optimization without any pharmacological treatment. A key aspect of our protective protocol
was the initial phase, during which the steady-state was progressively achieved over a 40-min
period. Indeed, although gradual increase in flow rate was adopted by most protocols, only few
studies included a slow re-warm of the lung and a delayed beginning of ventilation (Table 5)
[22, 26, 30]. The present model performed a stepwise enhancement of three crucial parame-
ters: temperature, flow rate, and tidal volume. Expressly, temperature was gradually aug-
mented because lungs were in hypothermic conditions after ice-cold flushing with Perfadex1.
We recommend assessing of the actual temperature of perfusion fluid, possibly in close prox-
imity to the graft. Flow rate was also increased stepwise to reduce hemodynamic stress. Of
note, in order to avoid hydrostatic edema, we elected to use a moderately low flow rate coupled
with an open atrium strategy [13], though this approach is typically associated with high flow
rates in the clinical setting [1]. Ventilation was started only when lung temperature reached
the physiological range. We used a protective ventilation strategy with a respiratory rate corre-
sponding to half the physiological value. Tidal volume was initially low and increased progres-
sively. The use of a gas mixture of room air supplemented with 5% CO2 enabled to overcome
Table 5. Comparison of reperfusion phase settings in recently reported rat EVLP protocols.
Author, ref Temperature, ˚C Perfusion Ventilation
Flow, % D PAP,
mmHg
Start,
min
VT, % D Ppeak,
cmH2O
PEEP,
cmH2O
RR,
bpm
RMs
Present model to 37.5 in 25 min B from 20 to 100% in 40
min
NR 25 from 70 to 100%
in 10 min
NR 3 35 -
Nelson[22] 37 to 100% in 15 min NR 0 to 100% in 15 min NR 2 NR sigh
Noda[26] from 20 to 37 in 30
min
from 10 to 100% in 60
min
5–10 20 NR 14–15 5 30 at 25
min
Markou[29] - - - - - - - - -
Motoyama[21] 37 from 10 to 100% in 10
min
NR 0 NR -8 C -4 C 60 NR
Dacho[28] - - - - - - - - -
Pêgo-
Fernandes[30]
NR from 14–20 to 100% in
10–15 min
<15–20 0 from 25 to 100%
in 10 min
NR NR 60 sigh
Hodyc[27] - - - - - - - - -
Inokawa[19] to 37 in 60 min B NR <20 60 100% <30 3 60 NR
Hirata [17] A 37 to 100% in 10 min NR 0 100% NR 2 40 NR
Liu[23] A 36–38 to 100% in 10 min NR 0 100% NR 3 40 at 0
min
Temperature, perfusion and ventilation settings in different research protocols are shown. “Reperfusion” denotes a transient phase in which the lungs are
gradually re-warmed, perfused and ventilated until the target values are reached.
ASingle-lung ex vivo perfusion.
B Lung temperature.
C Chamber pressure.
D Flow rate and VT are expressed as percent of target value.
Abbreviations: PAP, pulmonary artery pressure; VT, tidal volume; Ppeak, peak inspiratory pressure; PEEP, positive end expiratory pressure; RR,
respiratory rate; RMs, recruitment maneuvers; NR, not reported.
doi:10.1371/journal.pone.0167898.t005
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the lack of a membrane (de)oxygenator. Recruitment maneuvers were carried out twice during
the procedure to expand de-recruited areas.
This protocol was clearly adequate to sustain lung function, as indicated by gas analysis and
functional outcome assessments. Indeed, perfusate electrolyte composition as well as glucose
consumption and lactate production indicated active metabolism. In addition, airway and pul-
monary pressure remained in a physiological range during ex vivo perfusion. Finally, at the
end of the procedure, W/D ratio of perfused lungs was similar to that of controls, indicating
absence of edema.
Other important aspects had to be addressed in order to perform reproducible and success-
ful ex vivo perfusion.
The use of a surgical microscope allowed a better visualization of the pulmonary artery and
detection of gas embolism that represents the leading cause of non-homogeneous perfusion
patterns [22]. We also recommend the use of a pulmonary artery cannula equipped with a
bubble trap.
Though in EVLP rat models lungs are usually suspended from the tracheal and pulmonary
cannulae [19, 21, 22, 26, 27, 29, 30], we elected to put the graft horizontally, similar to the clini-
cal setting [1]. However, because rat lungs are fragile, we used an ad hoc modeled elastic sur-
face to avoid excessive pressure to soft tissues.
The perfusion fluid used in this model has the same principal components of STEEN solu-
tion™ that is generally used in the clinical setting [1]. The fluid consisted of an extracellular-
type solution supplemented with human serum albumin to reduce edema development,
heparin to avoid clot formation, dextran to prevent leukocyte adhesion [31], and glucose as
energy source. Moreover, unlike the majority of EVLP rat protocols (Table 4), we added anti-
biotics to the perfusion solution and checked for bacterial contamination at the end of each
procedure.
Table 6. Comparison of reconditioning phase settings in recently reported rat EVLP protocols.
Author, ref Temperature, ˚C Perfusion Ventilation
Flow, ml/min PAP, mmHg VT, ml/kg Ppeak, cmH2O PEEP, cmH2O RR, bpm RMs
Present model 37.5 B 5.7–7.6 NR 7 NR 3 35 at 45 and 175 min
Nelson[22] 37 5–10 NR 4 NR 2 NR sigh
Noda[26] 37 16.5 D 5–10 NR 14–15 5 30 -
Markou[29] 37 15 10 D 7 D NR 1–2 NR sigh
Motoyama[21] 37 10 NR NR -8 C -4 C 60 NR
Dacho[28] 37 0.08 D NR 6.2 D NR 2 60 NR
Pêgo-Fernandes[30] NR 5–7 <15–20 10 NR NR 60 sigh
Hodyc[27] 38 12 D NR NR NR NR NR -
Inokawa[19] 37 B NR <20 10 D <30 3 60 NR
Hirata[17] A 37 4 NR 5.5 D NR 2 40 NR
Liu[23] A 36–38 3.8 D NR 4 D NR 3 40 NR
Temperature, perfusion and ventilation settings in different research protocols are shown. The “reconditioning” phase achieves steady-state perfusion/
ventilation.
ASingle-lung ex vivo perfusion.
B Lung temperature.
C Chamber pressure.
D Measurement units were aligned.
Abbreviations: PAP, pulmonary artery pressure; VT, tidal volume; Ppeak, peak inspiratory pressure; PEEP, positive end expiratory pressure; RR,
respiratory rate; RMs, recruitment maneuvers; NR, not reported.
doi:10.1371/journal.pone.0167898.t006
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In clinical EVLP, the perfusate is replaced periodically to preserve lung function [13, 32].
However, we elected not to perform solution substitutions in order to evaluate concentration
of inflammatory mediators, cells, electrolytes, and metabolites over time. Interestingly, electro-
lyte and metabolite content was similar in samples collected from auricle and reservoir. On
the other hand, reservoir pO2 was lower relative to auricle pO2 because of gas exchange
between perfusion fluid and ambient air. Therefore, auricle withdrawal—that is unavoidably
associated with temperature and humidity perturbations caused by opening of lung chamber–
is essential for pO2 assessment but could be omitted to evaluate electrolyte or metabolite
concentration.
To facilitate reproduction of our model by other laboratories, instructional videos are pro-
vided. Indeed, direct observation of the crucial steps hastens improvement of learning curves
[33], in compliance with the 3Rs principles (Refinement, Reduction and Replacement) [9].
In conclusion, this paper provides a detailed description of a small animal model of EVLP
marked by prolonged ex vivo perfusion, optimal lung function, and absence of injury. This
goal was achieved through a stepwise modification of the protocols in use. The detailed
description of the approach to individual problems can help researchers to reproduce the
procedure.
A reliable preclinical model could be very helpful to improve ex vivo perfusion techniques
in both standard and marginal lungs and to investigate novel therapeutic intervention before
transplantation.
Supporting Information
S1 Fig. Bland-Altman plots. Agreement between measurements performed using auricle and
reservoir perfusate samples. Panel A: linear regression analysis. Panel B: Bland–Altman analy-
sis. Y-axis represents the difference between auricle and reservoir evaluations, while X-axis
represents the mean of the two measurements. Horizontal lines represent the mean difference
(solid lines) and the limits of agreement calculated as mean difference ± 2 times the standard
deviation (dashed lines).
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S1 Video. In situ lung function evaluation. Assessment of total lung capacity (TLC) and basal
elastance after performing a recruitment maneuver.
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S2 Video. In situ lung perfusion. Incannulation of pulmonary artery and resection of auricles
and heart apex.
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vivo perfusion.
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